Retraction: Identification of novel SCN5A single nucleotide variants in Brugada syndrome: a territory-wide study from Hong Kong
2024
Retraction of Study on SCN5A Variants in Brugada Syndrome
Retraction
Author Information
Author(s): Frontiers Editorial Office
Conclusion
The study was retracted due to lack of appropriate ethical approval.
Supporting Evidence
- The study did not receive appropriate ethical approval.
- The retraction was approved by the Chief Editors for Frontiers in Physiology.
Takeaway
The study about a heart condition was taken back because it didn't follow the rules for getting permission to do the research.
Potential Biases
The study's findings are compromised due to ethical concerns.
Limitations
The study lacked appropriate ethical approval.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website